Mydecine Innovations Group I
13F holders, Q1 2025 (March 31)1holders
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Mydecine Innovations Group I in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 0 sold out. The largest holder was Hurley Capital, LLC ($0).
- Company
- Mydecine Innovations Group I
- CUSIP
- 62849F200
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q1 2025: 100 shares bought, net +100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Hurley Capital, LLC | 0.00% | New | 100 | $0 |
"% of holder's portfolio" is MYDECINE INNOVATIONS GROUP I's weight in each manager's 13F, not the share of Mydecine Innovations Group I the manager owns.